NeuroMetrix logo

NeuroMetrixNASDAQ: NURO

Profile

Sector:

Healthcare

Country:

United States

IPO:

22 July 2004

Next earnings report:

21 February 2025

Last dividends:

28 March 2007

Next dividends:

N/A
$9.07 M
-81%vs. 3y high
17%vs. sector
-vs. 3y high
-vs. sector
-72%vs. 3y high
28%vs. sector
-59%vs. 3y high
42%vs. sector

Price

after hours | Wed, 20 Nov 2024 22:42:03 GMT
$4.44+$0.47(+11.84%)

Dividend

No data over the past 3 years
$587.30 K-$1.51 M

Analysts recommendations

Institutional Ownership

NURO Latest News

NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth
zacks.com06 November 2024 Sentiment: POSITIVE

Despite a 51% revenue dip, NURO narrowed losses in Q3 2024 by reducing operating expenses by 25%, offsetting the challenging revenue environment.

NeuroMetrix Reiterates its Review of Strategic Alternatives
globenewswire.com13 August 2024 Sentiment: NEUTRAL

WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives.

NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript
seekingalpha.com10 August 2024 Sentiment: NEUTRAL

NeuroMetrix, Inc. (NASDAQ:NURO ) Q2 2024 Earnings Conference Call August 6, 2024 8:00 AM ET Company Participants Thomas Higgins - Senior Vice President and Chief Financial Officer Shai Gozani - Founder and Chief Executive Officer Conference Call Participants Jarrod Cohen - JM Cohen & Company Operator Good morning, and welcome to the NeuroMetrix Second Quarter 2024 Business and Financial Update. My name is Amy, and I will be your moderator on the call.

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
globenewswire.com31 July 2024 Sentiment: POSITIVE

WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening of the market on August 6, 2024.

NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript
Seeking Alpha22 February 2024 Sentiment: NEUTRAL

NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
GlobeNewsWire08 January 2024 Sentiment: NEUTRAL

NeuroMetrix announced today that the Company's Chairman and CEO, Dr. Shai N. Gozani will present at the Emerging Growth Conference on January 10, 2024.

NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023
GlobeNewsWire28 September 2023 Sentiment: POSITIVE

WOBURN, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on October 4, 2023.

NeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023
GlobeNewsWire30 August 2023 Sentiment: POSITIVE

WOBURN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on September 6, 2023. This live, interactive, online event will give shareholders and the investment community the opportunity to interact in real time with the Company's Chairman and Chief Executive Officer, Dr. Shai N. Gozani. Dr. Gozani will present business highlights and recent developments, including the evolution of its Quell® neuromodulation technology. He will be available for questions from conference participants.

NeuroMetrix, Inc. Announces Date for Second Quarter 2023 Business and Financial Highlights Conference Call
GlobeNewsWire20 July 2023 Sentiment: NEUTRAL

WOBURN, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its Q2 2023 business and financial highlights before the opening of the market on July 27, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on July 27, 2023.

NeuroMetrix, Inc. (NURO) Q1 2023 Earnings Call Transcript
Seeking Alpha03 May 2023 Sentiment: NEUTRAL

NeuroMetrix, Inc. (NASDAQ:NURO ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Thomas Higgins - SVP, CFO & Treasurer Shai Gozani - Founder, Chairman, CEO, President & Secretary Conference Call Participants Operator Good morning, and welcome to the NeuroMetrix First Quarter 2023 Earnings Call. My name is Levay, and I'll be your moderator on the call.

What type of business is NeuroMetrix?

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

What sector is NeuroMetrix in?

NeuroMetrix is in the Healthcare sector

What industry is NeuroMetrix in?

NeuroMetrix is in the Medical Devices industry

What country is NeuroMetrix from?

NeuroMetrix is headquartered in United States

When did NeuroMetrix go public?

NeuroMetrix initial public offering (IPO) was on 22 July 2004

What is NeuroMetrix website?

https://www.neurometrix.com

Is NeuroMetrix in the S&P 500?

No, NeuroMetrix is not included in the S&P 500 index

Is NeuroMetrix in the NASDAQ 100?

No, NeuroMetrix is not included in the NASDAQ 100 index

Is NeuroMetrix in the Dow Jones?

No, NeuroMetrix is not included in the Dow Jones index

When was NeuroMetrix the previous earnings report?

No data

When does NeuroMetrix earnings report?

The next expected earnings date for NeuroMetrix is 21 February 2025